ARCHIVES

No Benefit For Cetuximab In Early-Stage Colon Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 12 | December 25, 2009

Download PDF Visit The Full Archive

Related Articles

DCT Board To Consider RFA for Clinical R01 Grants At Next Meetings

January 21, 1994

Computer Sciences Corp. Wins NIH Information System Contract

September 20, 2002

Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer

July 26, 2002

In Brief: FDA Commissioner Kessler Named Dean, Yale Medical School, Effective July 1

February 21, 1997

Rauscher Says He May Leave, But Will Stay Through June

February 6, 1976

In Brief: Debbie Mayer Elected ONS President; Cullen, Other NCI Staff Honored By Surgeon General

May 15, 1987